Exogenous Functional Mitochondria Derived from Bone Mesenchymal Stem Cells That Respond to ROS Can Rescue Neural Cells Following Ischemic Stroke
Lihua Dai,Zheqian Wu,Liili Yin,Longjian Cheng,Qiang Zhou,Fei Ding
DOI: https://doi.org/10.2147/jir.s463692
IF: 4.5
2024-05-24
Journal of Inflammation Research
Abstract:Lihua Dai, 1, &ast Zheqian Wu, 1, &ast Liili Yin, 1 Longjian Cheng, 1 Qiang Zhou, 2 Fei Ding 1 1 Department of Emergency, Shidong Hospital, ShangHai, People's Republic of China; 2 Department of General Surgery, Eighth People's Hospital, ShangHai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Ding; Qiang Zhou, Email ; Background: Upon uptake by stressed cells, functional mitochondria can perform their normal functions, ultimately enhancing the survival of host cells. However, despite the promising results of this approach, there is still a lack of understanding of the specific relationship between nerve cells and functional mitochondria. Methods: Functional mitochondria (F-Mito) were isolated from bone marrow-derived mesenchymal stem cells (BMSCs). The ability of microglia cells to internalize F-Mito was evaluated using a middle cerebral artery occlusion (MCAO) model in C57BL/6J mice and an oxygen-glucose deprivation/reoxygenation (OGD/R) cell model. After OGD/R and F-Mito treatment, the temporal dynamics of intracellular reactive oxygen species (ROS) levels were examined.The relationship between ROS levels and F-Mito uptake was assessed at the individual cell level using MitoSOX, Mitotracker, and HIF-1α labeling. Results: Our findings indicate that microglia cells exhibit enhanced mitochondrial uptake compared to astrocytes. Furthermore, internalized F-Mito reduced ROS levels and HIF-1α levels. Importantly, we found that the ROS response in microglia cells following ischemia is a critical regulator of F-Mito internalization, and promoting autophagy in microglia cells might reduce the uptake of ROS and HIF-1α levels. Conclusion: It is verified that F-Mito derived from BMSCs play a protective role in ischemia-reperfusion injury, as their weakening reduces microglial cell activation and alleviates neuroinflammation. Keywords: neuroinflammation, ROS, stem cell, HIF-1α, ischemic stroke Stroke is one of the leading causes of death and disability globally, second only to ischemic heart disease. Stroke has become a major cause of premature death and disease burden. The treatment for acute ischemic stroke aims to restore perfusion to brain tissue and can be achieved through thrombolytic drugs or endovascular therapy. However, only a small percentage of stroke patients actually receive acute treatment. Administering thrombolytic therapy within 4.5 hours of stroke onset is the most effective treatment for acute ischemic stroke. 1,2 Research suggests that approximately 25% of ischemic stroke patients are eligible for thrombolytic therapy, and 10–12% are suitable for endovascular treatment. Without treatment intervention, the ischemic area may expand over time to surrounding areas, leading to additional cell death in the days or weeks following stroke and infarction. Although treatment within the effective window can reduce the mortality rate after ischemic stroke, over 60% of stroke survivors still face varying degrees of motor, cognitive, language, and swallowing impairments. These consequences can severely impair their ability to care for themselves, lower their quality of life, and increase the burden on their families and society. Therefore, there is an urgent need for more effective stroke treatments. 3,4 The administration of bone marrow stem cells emerges as a promising novel approach in addressing nerve damage resulting from hypertension and stroke. Prior research has demonstrated the potential of bone marrow stem cells to enhance the rehabilitation of limb dysfunction in individuals affected by ischemic stroke, while also mitigating concurrent dysfunctions. 5,6 Mitochondria demonstrate significant functional adaptability within cells to meet local metabolic demands. Observations have shown the internalization of exogenous mitochondria in microglia and endothelial cells following an ischemic stroke, promoting the survival and activity of endogenous cells. 7,8 Nevertheless, the precise uptake of exogenous mitochondria by microglia cells after an ischemic stroke remains unclear. Recent research has revealed that cellular oxidative stress is a prerequisite for the transfer of mitochondria within the cell. Under conditions of glucose and oxygen deprivation, followed by reoxygenation, endothelial or myocardial cells can acquire mitochondria from MSCs to improve their survival. Similarly, paclitaxel treatment increases the transfer of mitochondria from MSCs to injured endothelial cells, while ethidium bromide treatment enhances the transport of mitochondria from mesenchymal stem cells to treated osteosarcoma cell. 9,1 -Abstract Truncated-
immunology